How Does Circadin Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Circadin (Melatonin) Works

  • Active substance: Melatonin, a natural hormone that regulates the sleep‑wake cycle.
  • Primary action: Binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus.
  • Physiological effect: Promotes sleep onset and helps maintain sleep (prolonged‑release formulation).
  • Onset: Take 1–2 hours before bedtime; works with the body’s natural rhythm.
  • Duration: Prolonged‑release tablet provides melatonin gradually over 8–10 hours.
  • Indication: Short‑term treatment of primary insomnia in patients aged 55 years and older.

Circadin (melatonin) is a naturally occurring hormone that helps reset your internal body clock and improve sleep quality. This guide explains the science behind how it works.

Important Medical Advice

If you experience chest pain, fainting, severe dizziness, or signs of an allergic reaction (swelling of face/tongue, difficulty breathing), stop taking Circadin and seek immediate medical help. Do not drive if you feel drowsy. Avoid alcohol while on Circadin. Always consult your doctor before starting melatonin, especially if you have liver or kidney problems, an autoimmune disease, or are taking other medications.

Chemical Composition & Molecular Structure

The active substance in Circadin is melatonin (N‑acetyl‑5‑methoxytryptamine), a hormone naturally produced by the pineal gland. Its synthetic form is identical to the endogenous molecule.

Chemical Structure Details

Chemical Name

N‑[2‑(5‑methoxy‑1H‑indol‑3‑yl)ethyl]acetamide

This indole‑based structure allows melatonin to cross the blood‑brain barrier and bind selectively to melatonin receptors.

Molecular Formula

C13H16N2O2

13 carbon, 16 hydrogen, 2 nitrogen, and 2 oxygen atoms.

Molecular Weight

232.28 g/mol

Low molecular weight facilitates rapid absorption and distribution.

Pharmaceutical Properties of Circadin 2 mg Prolonged‑Release Tablets

PropertyValue / CharacteristicClinical Significance
SolubilitySlightly soluble in water; lipophilicEnables passage through cell membranes and blood‑brain barrier
pKaApprox. 10.8 (weak base)Mostly unionised at physiological pH, favouring tissue penetration
Protein Binding~60% (mainly to albumin)Moderate binding allows sufficient free fraction for receptor interaction
ExcipientsAmmonio methacrylate copolymer, calcium hydrogen phosphate, lactose, silica, talc, magnesium stearateProlonged‑release matrix ensures gradual melatonin release

🗒️ Pharmaceutical Insight: Circadin’s prolonged‑release formulation uses a pH‑dependent copolymer to delay dissolution, mimicking the body’s natural nocturnal melatonin secretion profile.

Mechanism of Action: How Melatonin Regulates Sleep

Melatonin is the key hormonal signal for darkness. It synchronises the circadian rhythm with the environmental light‑dark cycle.

Key Steps in Melatonin’s Action

  1. Darkness triggers production: Naturally, melatonin rises in the evening. Circadin provides an external source.
  2. Receptor binding: Melatonin binds to MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus.
  3. Neuronal inhibition (MT1): MT1 activation reduces SCN neuronal firing, promoting sleep onset.
  4. Phase shifting (MT2): MT2 activation advances or delays the circadian clock, reinforcing the sleep‑wake rhythm.
  5. Vascular effects: Melatonin also causes vasodilation in peripheral vessels, contributing to the drop in core body temperature that facilitates sleep.

🗒️ Physiological Insight: Unlike traditional sleeping pills, melatonin does not sedate the brain directly; it “opens the gate” for sleep by timing the body clock.

Melatonin Receptors in the Brain

Two high‑affinity G‑protein coupled receptors mediate melatonin’s effects:

ReceptorLocationFunction
MT1SCN, hippocampus, retinaInhibits neuronal firing → promotes sleepiness; vasoconstriction in some vessels
MT2SCN, retina, ovariesPhase‑shifts circadian rhythms; vasodilation in arteries

Both receptors are also found in peripheral tissues, explaining melatonin’s roles in immunity, antioxidant defence, and reproduction.

Metabolic Effects & Duration in the Body

Melatonin is rapidly metabolised, but Circadin’s prolonged‑release design sustains levels throughout the night.

Metabolic Pathway

Primary metabolism

Liver: Mainly by CYP1A2 (and minor CYP2C19) to 6‑hydroxymelatonin, then conjugated to 6‑sulfatoxymelatonin.

Elimination

Urine: 80% as 6‑sulfatoxymelatonin; faeces: minor.

Half‑life

Immediate‑release: 30–60 min; prolonged‑release: 3.5–4 h (but with extended absorption phase).

Duration of Action

After a 2 mg dose, melatonin levels rise slowly, peak at 2–3 hours, and remain above baseline for 8–10 hours, supporting sleep maintenance without excessive morning levels.

Absorption, Distribution & Elimination

ParameterValue
Bioavailability~15% (due to extensive first‑pass metabolism)
Peak concentration (Cmax)~1.5–2 hours after intake (prolonged‑release)
Volume of distribution~1–2 L/kg – widespread tissue distribution
Protein binding60% (albumin)
Elimination half‑life3.5–4 hours (parent drug)

🗒️ Food effect: Taking Circadin after a meal delays absorption slightly but does not reduce overall exposure. Smoking (CYP1A2 inducer) can lower melatonin levels – inform your doctor if you smoke.

Clinical Efficacy for Primary Insomnia

Circadin is indicated for short‑term treatment (up to 13 weeks) of primary insomnia in patients ≥55 years.

OutcomeEffect vs. placebo
Sleep onset latencyReduced by 10–15 minutes
Sleep qualitySignificant improvement (subjective and actigraphy)
Morning alertnessNo impairment – no “hangover” effect

Melatonin does not cause dependence or withdrawal, making it suitable for older adults with chronic insomnia.

Circadin Mechanism FAQs

Circadin is a prolonged‑release formulation designed to release melatonin gradually over 8–10 hours, mimicking the natural overnight secretion. Standard immediate‑release tablets raise levels quickly but fall within 2–3 hours, which may not sustain sleep.

Circadin should be taken 1–2 hours before bedtime. Melatonin levels begin to rise within 30–60 minutes, and the sleep‑promoting effect is usually felt within 1–2 hours.

No. Melatonin does not cause dependence or withdrawal. It regulates the body clock rather than sedating the brain, so it is not habit‑forming.

Alcohol reduces the effectiveness of melatonin and can increase drowsiness. It is best to avoid alcohol before, during, or after taking Circadin.

Taking more than the recommended dose may cause drowsiness, headache, or dizziness. If you accidentally take too much, contact your doctor or pharmacist.

Need Help with Jet Lag or Poor Sleep?

If you're 55 or over and struggling with sleep onset or quality, Circadin may help reset your sleep pattern. A UK‑registered doctor can advise if melatonin is suitable for you.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | Trusted by thousands

Start Jet Lag Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 16 February 2026

Next Review: 16 August 2026

Published on: 16 February 2026

Last Updated: 16 February 2026